So the obvious inference from that is that instos are leaving it...

So the obvious inference from that is that instos are leaving it retailers..... i hope this coming quarterly sheds a lot more light on where they think their future rev is going to come from....just saying the pipeline is not enough. There is no confidence in the pipeline. They cant influence the ibm customers and i hope they are not overly relying on that. Hopefully the clinical mkt is getting some traction. I think they need a direct to consumer path that they control..As frustrated as i am i am holding i see no point in jumping out now, will ride it to bang or bust.